Co-targeting aurora kinase with PD-L1 and PI3K abrogates immune checkpoint mediated proliferation in peripheral T-cell lymphoma: a novel therapeutic strategy.

Islam, Shariful; Vick, Eric; Huber, Bryan; Morales, Carla; Spier, Catherine; Cooke, Laurence; Weterings, Eric; Mahadevan, Daruka

Islam, Shariful; Vick, Eric; Huber, Bryan; Morales, Carla; Spier, Catherine; Cooke, Laurence; Weterings, Eric; Mahadevan, Daruka.

Afiliação

Islam S; Cancer Biology GIDP, University of Arizona Cancer Center, Tucson, AZ 85724, USA.
Vick E; West Cancer Center and University of Tennessee Health Sciences Center, Memphis, TN 38163, USA.
Huber B; West Cancer Center and University of Tennessee Health Sciences Center, Memphis, TN 38163, USA.
Morales C; West Cancer Center and University of Tennessee Health Sciences Center, Memphis, TN 38163, USA.
Spier C; Department of Hematopathology, University of Arizona, Tucson, AZ 85724, USA.
Cooke L; Department of Medicine, The University of Arizona Cancer Center, Tucson, AZ 85724, USA.
Weterings E; Department of Radiation Oncology, University of Arizona, Tucson, AZ 85724, USA.
Mahadevan D; Department of Medicine, The University of Arizona Cancer Center, Tucson, AZ 85724, USA.

Oncotarget ; 8(59): 100326-100338, 2017 Nov 21.

Article em En | MEDLINE | ID: mdl-29245981